Prozinc Veterinary Insulin Syringe 1ML 10PCS

Prozinc Veterinary Insulin is an injectable solution developed specifically for the management of diabetes mellitus in cats and dogs. The package contains 10 bottles of 1 ml each, designed for practical and accurate use in the daily administration of the insulin drug. This galvanized protamine insulin product helps regulate blood sugar, offering a slow, sustained release that provides better diabetes control than other faster-acting insulin types. The drug is essential for improving the quality of life of the diabetic animal, helping to regulate blood glucose values ​​in a stable and long-lasting way and preventing complications associated with high or fluctuating blood glucose values. Designed to specifically adapt to the physiological needs of pets, Prozinc Veterinary Insulin also facilitates owner compliance with treatment, thanks to a formulation suitable for outpatient and home administration, minimizing the risk of error and side effects. This makes it a reference choice in the long-term management of diabetes in dogs and especially in cats, which requires stable, safe and predictable insulin treatment.

Therapeutic Indications

Prozinc Veterinary Insulin is indicated for the treatment of diabetes mellitus in dogs and cats, pathologies characterized by deficiency or altered activity of insulin produced by the body which lead to marked fluctuations in blood glucose levels. It is particularly indicated in animals that present classic symptoms such as polyuria, polydipsia, weight loss and increased appetite despite regular food intake. Its use allows you to normalize blood sugar levels and reduce the clinical symptoms of diabetes, thus improving the general well-being and physical condition of affected animals. Prozinc is also recommended in subjects who need a precise therapeutic approach, thanks to the possibility of modulating the dosage by adapting it to the glycemic response monitored daily. Galvanized protamine insulin allows a constant release of the active ingredient, ensuring optimal metabolic coverage throughout the day and reducing the need for multiple daily administrations, thus simplifying daily management for the owner and the animal. The product can be included in an integrated plan that includes regular glycemic checks, appropriate diet and physical activity, helping to prevent long-term complications such as cataracts, diabetic neuropathy and secondary infections, improving the life expectancy of diabetic dogs and cats.

Composition

Active ingredient: Each ml of solution contains galvanized protamine insulin, a prolonged-release form of insulin designed to resemble the natural insulin produced by the body as much as possible. The particular composition of this insulin makes it compatible with the animal organism, reducing the possibility of adverse reactions typical of less species-specific drugs. In addition to the active ingredient, each 1 ml bottle contains selected excipients such as protamine sulphate, zinc chloride, and other stabilizers which allow a uniform release of insulin at the injection site and maintain the stability of the solution. All components are chosen to minimize the risk of allergic reactions and to guarantee safe use even in sensitive subjects, ensuring maximum effectiveness of the therapy in the short and long term. The formulation guarantees the integrity of the active ingredient until the last administration of each bottle, avoiding contamination and ensuring precision in the dose administered thanks to the use of specific graduated syringes for low-volume insulin, a fundamental element for the correct management of diabetes in pets.

Contraindications

The administration of Prozinc Veterinary Insulin is contraindicated in cases of known hypersensitivity to protamine galvanized insulin or to any of the excipients present in the formulation. It must not be used in animals experiencing episodes of hypoglycaemia or in subjects with serious concomitant diseases resulting in an acute uncontrolled metabolic imbalance, such as severe uncompensated liver or kidney failure. Use must also be avoided in animals in which a correct diagnosis of diabetes mellitus has not been made, to prevent the risk of potentially lethal hypoglycaemic crises. Prozinc is not indicated in young, unweaned animals and must not be administered simultaneously with other oral hypoglycemic drugs without strict veterinary supervision, due to the risk of interactions that can profoundly alter blood sugar levels. Use during pregnancy and breastfeeding is not recommended unless the benefit for the animal outweighs the potential risk, under prescription and careful monitoring by the responsible veterinarian. In case of proven intolerance or serious adverse reaction, immediately suspend treatment and consult your veterinarian.

Safety of the drug for the species

Prozinc Veterinary Insulin has been extensively tested on dogs and cats to guarantee its safety of use and tolerability during chronic treatments. Clinical studies and veterinary experience document that, if administered according to the recommended doses and under the supervision of a veterinarian, the risk of side effects is limited; however, like any insulin, the drug can lead to the possible development of hypoglycemia if overdosed or if the animal's nutritional and health conditions are not constantly monitored. Any adverse reactions, such as local irritation at the injection site, are generally transient and modest, but must still be reported to the veterinarian. The product provides a safety margin even in the event of slight dosage errors, but one should never neglect to evaluate each patient individually and adjust the dosage in the event of changes in body weight, state of health or diet. Safety protocols recommend regularly monitoring the animal's glycemic values ​​and providing detailed instructions to owners, so that they can promptly recognize the signs of a hypoglycemic crisis and intervene promptly. The use of Prozinc must always be accompanied by correct education on the recognition of risk situations and on the importance of respecting doses and administration times, to guarantee effective and safe therapy in the long term.

Precautions

When treating with Prozinc Veterinary Insulin it is essential to maintain close veterinary supervision, especially in the initial phases of treatment or during any change in dosage. The owner must be carefully instructed on the correct method of storing the drug (in the refrigerator between 2° and 8°C), on the technique of aseptic withdrawal of the solution and on the methods of subcutaneous injection to minimize the risk of infection and ensure accurate dosing. It is essential to replace the bottle according to the indications, avoid use beyond the expiry date and check the appearance of the solution before administration: in the presence of turbidity, change in color or presence of particulate matter, the solution must be thrown away. Pay particular attention to debilitated, elderly or comorbid animals, as they may require dose adjustments. Syringes should not be shared between multiple animals to avoid cross-contamination. Owners must be informed of the clinical signs of hypoglycemia (asthenia, tremors, loss of coordination, seizures, fainting) and trained to intervene if necessary by administering sugar or honey and contacting the veterinarian immediately. Always wash your hands after handling Prozinc and carefully dispose of disposable materials. Keep the medicine out of the reach of children.

Method of administration

Prozinc Veterinary Insulin must be administered exclusively subcutaneously, following the instructions provided by the veterinarian who will establish the exact dosage based on the specific needs of each animal. It is advisable to always use specific low-volume insulin syringes, which guarantee precise dosing even for minimal variations in therapeutic needs. Before administration, shake the bottle gently to obtain a uniform suspension of the active ingredient; do not shake vigorously to avoid the formation of bubbles which could compromise the precision of the dose. Withdraw the prescribed amount and gently inject the solution into the subcutaneous tissue of the chosen area (typically the neck or flank), alternating injection sites from day to day to prevent local irritation or lipodystrophy. It is preferable to always administer insulin at the same time, generally after the main meal of the day, to synchronize the action of the drug with the absorption of nutrients and reduce the risk of hypoglycemia. Carefully follow veterinary recommendations for storage and disposal of bottles and syringes. Any deviations in the diet, changes in the state of health or new medications must be promptly communicated to the veterinarian, who will evaluate the need to modify the schedule and dosage of Prozinc administration.

Treatment program

The treatment program with Prozinc Veterinary Insulin is personalized by the veterinarian based on the glycemic response of the individual animal, which must be monitored with regular blood sugar measurements and the evaluation of clinical symptoms. Generally, the therapy involves one or two injections a day, at fixed times, always at meals to optimize the stability of blood glucose. In the initial phase of treatment, gradual adjustments of the dose are carried out, evaluating the glycemic curve at several points during the day and observing the behavior and clinical response of the animal; this allows the minimum effective dose to be identified, minimizing the risk of side effects. Over time, slight adjustments may be necessary depending on body weight, age, general health or any changes in diet and physical activity. It is essential that the owner is actively involved in home blood sugar monitoring, noting changes and promptly reporting them to the veterinarian. A regular visit program allows you to prevent complications and keep diabetes under control, improving the pet's prognosis and quality of life. In case of pregnancy, breastfeeding or presence of other diseases, the treatment regimen will be evaluated and, if necessary, modified by the veterinarian.

Target species

Prozinc Veterinary Insulin is indicated for exclusive use on dogs and cats suffering from diabetes mellitus. Its specific formulation for veterinary medicine makes it suitable both for the treatment of diabetes in dogs, where the pathology tends to be insulin-dependent, and in cats, where diabetes can take variable forms and the insulin response requires personalized and dynamic management. The possibility of adapting the dosage to the different needs of species and subjects allows flexible, precise and effective management of the endocrine disease, in full compliance with animal safety and well-being.